Cargando…

Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria

The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Jia, Li, Lian, Yu, Jie, Hu, Hong-Yu, Liu, Zi-Xu, Jiang, Wen-Jie, Xu, Wei, Guo, Xue-Ping, Wang, Feng-Shan, Sheng, Ju-Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937569/
https://www.ncbi.nlm.nih.gov/pubmed/36800421
http://dx.doi.org/10.1126/sciadv.ade4770
_version_ 1784890451155746816
author Wang, Yu-Jia
Li, Lian
Yu, Jie
Hu, Hong-Yu
Liu, Zi-Xu
Jiang, Wen-Jie
Xu, Wei
Guo, Xue-Ping
Wang, Feng-Shan
Sheng, Ju-Zheng
author_facet Wang, Yu-Jia
Li, Lian
Yu, Jie
Hu, Hong-Yu
Liu, Zi-Xu
Jiang, Wen-Jie
Xu, Wei
Guo, Xue-Ping
Wang, Feng-Shan
Sheng, Ju-Zheng
author_sort Wang, Yu-Jia
collection PubMed
description The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides of Escherichia coli and Bacillus subtilis via bacterial metabolism. Targeted metabolic labeled hyaluronan and the precursors of heparin and chondroitin sulfate were obtained. The azido-labeled polysaccharides (purified or in capsules) were reacted with dyes, via bioorthogonal chemistry, to enable detection and imaging. Site-specific introduction of fluorophores directly onto cell surfaces affords another choice for observing and quantifying bacteria in vivo and in vitro. Furthermore, azido-polysaccharides retain similar biological properties to their natural analogs, and reliable and predictable introduction of functionalities, such as fluorophores, onto azido-N-hexosamines in the disaccharide repeat units provides chemical tools for imaging and metabolic analysis of GAGs in vivo and in vitro.
format Online
Article
Text
id pubmed-9937569
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-99375692023-02-18 Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria Wang, Yu-Jia Li, Lian Yu, Jie Hu, Hong-Yu Liu, Zi-Xu Jiang, Wen-Jie Xu, Wei Guo, Xue-Ping Wang, Feng-Shan Sheng, Ju-Zheng Sci Adv Biomedicine and Life Sciences The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides of Escherichia coli and Bacillus subtilis via bacterial metabolism. Targeted metabolic labeled hyaluronan and the precursors of heparin and chondroitin sulfate were obtained. The azido-labeled polysaccharides (purified or in capsules) were reacted with dyes, via bioorthogonal chemistry, to enable detection and imaging. Site-specific introduction of fluorophores directly onto cell surfaces affords another choice for observing and quantifying bacteria in vivo and in vitro. Furthermore, azido-polysaccharides retain similar biological properties to their natural analogs, and reliable and predictable introduction of functionalities, such as fluorophores, onto azido-N-hexosamines in the disaccharide repeat units provides chemical tools for imaging and metabolic analysis of GAGs in vivo and in vitro. American Association for the Advancement of Science 2023-02-17 /pmc/articles/PMC9937569/ /pubmed/36800421 http://dx.doi.org/10.1126/sciadv.ade4770 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Wang, Yu-Jia
Li, Lian
Yu, Jie
Hu, Hong-Yu
Liu, Zi-Xu
Jiang, Wen-Jie
Xu, Wei
Guo, Xue-Ping
Wang, Feng-Shan
Sheng, Ju-Zheng
Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title_full Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title_fullStr Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title_full_unstemmed Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title_short Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
title_sort imaging of escherichia coli k5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937569/
https://www.ncbi.nlm.nih.gov/pubmed/36800421
http://dx.doi.org/10.1126/sciadv.ade4770
work_keys_str_mv AT wangyujia imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT lilian imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT yujie imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT huhongyu imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT liuzixu imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT jiangwenjie imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT xuwei imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT guoxueping imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT wangfengshan imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria
AT shengjuzheng imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria